TM4SF5 expression can be induced by inflammatory cytokines and can eventually lead to NASH in the presence of chronic metabolic abnormalities in the liver, frequently causing remodeling of the inflammatory environment through interactions with immune cells [9,13]. The gene discussed is TM4SF5; the disease is metabolic dysfunction-associated steatohepatitis.